Published November 15, 2018
| Version v1
Patent
Open
Antisense Polynucleotides to Induce Exon Skipping and Method of Treating Dystrophies
Contributors
Patent applicant:
Description
Antisense polynucleotides and their use in pharmaceutical compositions to induce exon skipping in targeted exons of the gamma sarcoglycan gene are provided, along with methods of preventing or treating dystrophic diseases such as Limb-Girdle Muscular Dystrophy.
Files
US20180327743.pdf
Files
(1.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:bc85c0fc8144a612449df29dd3ab3cda
|
1.9 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201816041278 A
- Patent number
- US 2018/0327743 A1
- Other
- oai:uchicago.tind.io:9062
Dates
- Patent filed
-
2018-07-20